Ten years experience of in-center thrice weekly long overnight hemodialysis

Clinical Journal of the American Society of Nephrology

Volumn 4, Issue 6, 2009, Pages 1097-1101

  Powell, Joanna Ruth ^a   Oluwaseun, Oyeniran ^a   Woo, Yook Mun ^b   Padmanabhan, Neal ^a   Narasinghan, Eliyanachii ^c   Latta, Carol ^a   Tortolano, Julie ^b   Jardine, Alan G ^a,c   Geddes, Colin C ^a  

^a WESTERN INFIRMARY   (United Kingdom)

^b Inverclyde Royal Infirmary   (United Kingdom)

^c UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; ERYTHROPOIETIN; HEMOGLOBIN; IRON SACCHARATE; NOVEL ERYTHROPOIESIS STIMULATING PROTEIN; PHOSPHATE BINDING AGENT; UREA; PHOSPHATE;

ADULT; ANEMIA; ARTERIOVENOUS FISTULA; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; FERRITIN BLOOD LEVEL; HEMODIALYSIS; HUMAN; HYPERPHOSPHATEMIA; LONG OVERNIGHT HEMODIALYSIS; MAJOR CLINICAL STUDY; MALE; PROGNOSIS; RENAL REPLACEMENT THERAPY; SYSTOLIC BLOOD PRESSURE; TREATMENT DURATION; AGED; BLOOD; BLOOD PRESSURE; CASE CONTROL STUDY; CHRONIC KIDNEY FAILURE; METABOLISM; METHODOLOGY; MIDDLE AGED; PATIENT CARE; PATIENT SATISFACTION;

ADULT; AGED; ANEMIA; BLOOD PRESSURE; CASE-CONTROL STUDIES; ERYTHROPOIETIN; FEMALE; HEMOGLOBINS; HUMANS; HYPERPHOSPHATEMIA; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; NIGHT CARE; PATIENT SATISFACTION; PHOSPHATES; RENAL DIALYSIS; UREA;

EID: 69249214277     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.06651208     Document Type: Article

References (18)

1. Lowrie EG, Laird NM, Parker TF, Sargent JA: Effect of the hemodialysis prescription of patient morbidity: Report from the National Cooperative Dialysis Study. N Engl J Med 305: 1176-1181, 1981
2. Laurent G, Charra B: The results of an 8 h thrice weekly haemodialysis schedule. Nephrol Dial Transplant 13 Suppl 6: 125-131, 1998
3. Lindsay RM, Alhejaili F, Nesrallah G, Leitch R, Clement L, Heidenheim AP, Kortas C: Calcium and phosphate balance with quotidian hemodialysis. Am J Kidney Dis 42: 24-29, 2003
4. Lindsay RM, Leitch R, Heidenheim AP, Kortas C: The London Daily/Nocturnal Hemodialysis Study-study design, morbidity, and mortality results. Am J Kidney Dis 42: 5-12, 2003
5. Nesrallah G, Suri R, Moist L, Kortas C, Lindsay RM: Volume control and blood pressure management in patients undergoing quotidian hemodialysis. Am J Kidney Dis 42: 13-17, 2003
6. Rao M, Muirhead N, Klarenbach S, Moist L, Lindsay RM: Management of anemia with quotidian hemodialysis. Am J Kidney Dis 42: 18-23, 2003
7. Suri R, Depner TA, Blake PG, Heidenheim AP, Lindsay RM: Adequacy of quotidian hemodialysis. Am J Kidney Dis 42: 42-48, 2003
8. Uldall R, Ouwendyk M, Francoeur R, Wallace L, Sit W, Vas S, Pierratos A: Slow nocturnal home hemodialysis at the Wellesley Hospital. Adv Ren Replace Ther 3: 133-136, 1996
9. Weinreich T, De los Rios T, Gauly A, Passlick-Deetjen J: Effects of an increase in time vs. frequency on cardiovascular parameters in chronic hemodialysis patients. Clin Nephrol 66: 433-439, 2006
10. Mactier, R: Module 3a - Clinical practice guidelines for Haemodialysis. The Renal Association 4th Edition, 2007
11. Cassidy M, Richardson D, Jones, C: Module 2 - Complications. The Renal Association. 2007
12. US Renal Data System: USRDA 1991 Annual Report. The National Institute of Diabetes and Digestive and Kidney Diseases. Bethesda, USRDA, 1991
13. Heidenheim AP, Muirhead N, Moist L, Lindsay RM: Patient quality of life on quotidian hemodialysis. Am J Kidney Dis 42: 36-41, 2003
14. Kurella M, Chertow GM: Dialysis session length ("t") as a determinant of the adequacy of dialysis. Semin Nephrol 25: 90-95, 2005
15. Charra B, Calemard E, Ruffet M, Chazot C, Terrat JC, Vanel T, Laurent G: Survival as an index of adequacy of dialysis. Kidney Int 41: 1286-1291, 1992
16. Saran R, Bragg-Gresham JL, Levin NW, Twardowski ZJ, Wizemann V, Saito A, Kimata N, Gillespie BW, Combe C, Bommer J, Akiba T, Mapes DL, Young EW, Port FK: Longer treatment time and slower ultrafiltration in hemodialysis: Associations with reduced mortality in the DOPPS. Kidney Int 69: 1222-1228, 2006
17. Marshall MR, Byrne BG, Kerr PG, McDonald SP: Associations of hemodialysis dose and session length with mortality risk in Australian and New Zealand patients. Kidney Int 69: 1229-1236, 2006
18. Charra B, Chazot C, Jean G, Hurot JM, Vanel T, Terrat JC, VoVan C: Long 3 x 8 hr dialysis: A three-decade summary. J Nephrol 16 Suppl 7: S64-S69, 2003